Sepsis Clinical Trials

Find Sepsis Clinical Trials Near You

Volume Kinetics of Fluid Resuscitation With 30 ml/kg Ringer Lactate in Early Sepsis

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY

The recommended volume resuscitation for patients with early sepsis-induced hypoperfusion is at least 30 ml/kg of crystalloid administered within the first three hours. However, this standardized approach does not account for individual patient variability and lacks personalization. Additionally, the effects of administering 30 ml/kg on intercompartmental fluid shifts between the plasma and interstitial compartments remain unclear. This study aims to describe the volume kinetics of administering 30 ml/kg of Ringer's Lactate in patients with early sepsis-induced hypoperfusion within the first three hours.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ A diagnosis of sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation:

• hypotension requiring norepinephrine to maintain a mean arterial blood pressure (MAP) either predefined by the clinician or at 65 mm Hg or higher and/or

• a serum lactate level \>2 mmol/L (18mg/dL) and/or

• acute oliguria defined as urine output \<0.5mL/kg/hr and/or

• mottled skin and/or

• capillary refill time \> 3 seconds.

Locations
Other Locations
Romania
Fundeni Clinical Institute
RECRUITING
Bucharest
Prof CC Iliescu Emergency Institue for Cardiovascular Diseases
RECRUITING
Bucharest
Contact Information
Primary
Cosmin Balan, PhD
cosmin13mara@yahoo.com
0722751501
Time Frame
Start Date: 2024-06-19
Estimated Completion Date: 2026-07-30
Participants
Target number of participants: 15
Treatments
Ringer's Lactate
Adult patients admitted in the intensive care unit (ICU) with sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation (i.e., 30 ml/kg crystalloid).
Related Therapeutic Areas
Sponsors
Leads: Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu

This content was sourced from clinicaltrials.gov